<DOC>
	<DOCNO>NCT00280592</DOCNO>
	<brief_summary>Bladder dysfunction occur time patient multiple sclerosis patient prone recurrent urinary tract infection . Cranberry traditionally use treatment prophylaxis urinary tract infection reliable randomize control trial demonstrate evidence cranberry 's utility disease . The aim study assess efficacy safety cranberry prophylaxis urinary tract infection patient multiple sclerosis prospective randomize , double-blind placebo-controlled clinical trial .</brief_summary>
	<brief_title>Cranberry Prevention Urinary Tract Infections Multiple Sclerosis Patients</brief_title>
	<detailed_description>Bladder dysfunction occur time 70 90 % patient multiple sclerosis patient prone recurrent urinary tract infection ( UTI ) , lead important morbidity . Cranberry traditionally use treatment prevention UTI research suggest mechanism action prevent bacterial adherence host cell surface membrane . However , systematic review show small sample size poor quality available trial , determine reliable evidence effectiveness cranberry UTI prophylaxis . Therefore , ass whether cranberry effective reduce UTI patient multiple sclerosis , design randomize , double-blind , placebo-controlled trial . Efficacy evaluate time onset UTI first year treatment .</detailed_description>
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Sclerosis</mesh_term>
	<mesh_term>Multiple Sclerosis</mesh_term>
	<mesh_term>Urinary Tract Infections</mesh_term>
	<criteria>Adults age 18 70 , multiple sclerosis , neurologically stable least 3 month With EDSS score â‰¥ 3 Symptomatic bladder dysfunction : frequency , urgency , dysuria , incontinence ( least one symptom ) , need intermittent catheterization Ambulatory inclusion Able undergo evaluation Informed write consent Noninclusion Criteria : Regular consumption cranberry within 3 month inclusion Symptomatic urinary tract infection inclusion Chronic renal failure ( creatinin clearance &lt; 10ml/min ) Patients urinary permanent catheterization Patients hyperuricemia risk uric acid lithiasis Patients oral anticoagulant treatment ( antivitamins K ) Peptic ulcer Intolerance cranberry and/or excipients Urinary tract infection antibioprophylaxis</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>May 2008</verification_date>
	<keyword>Prophylaxis</keyword>
	<keyword>Cranberry</keyword>
	<keyword>Neurogenic bladder</keyword>
</DOC>